To the Editor: In their Commentary on a new policy framework for the biomedical research enterprise, Drs Federoff and Rubin1 argued persuasively for reforms that could rid the research enterprise of boom-bust cycles, close funding gaps, and depoliticize interest group–driven funding decisions. The authors called for a coherent and inclusive policy advisory system that would have the support of policy makers and professional societies alike.
Perzynski AT. Multidisciplinary Approaches to Biomedical Research. JAMA. 2010;304(20):2243-2244. doi:10.1001/jama.2010.1703